Login to Your Account

Financings Roundup

Antibiotic Developer Tetraphase Prices Initial Public Offering

By Peter Winter
BioWorld Insight Editor

Thursday, March 21, 2013
Antibiotic drug developer Tetraphase Pharmaceuticals Inc., of Watertown, Mass., joined recent publicly listed antibiotic-focused biotechnology companies Trius Therapeutics Inc. (2010) and Cempra Inc. (2012) by pricing its initial public offering (IPO) Wednesday. The company also achieved its objective of raising $75 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription